Immunotherapy in pancreatic cancer: Unleash its potential through novel combinations

DOI: 10.5306/wjco.v8.i3.230

Keywords: Immunotherapy, Pancreatic cancer, Anti-programmed cell death protein-1, Anti-programmed cell death protein-ligand1, Anti-cytotoxic T lymphocyte antigen-4, Single therapy, Combination therapies, Radiation therapy, GVAX, CRS-207, CD40 agonist

Full-Text   Cite this paper   Add to My Lib

Abstract:

Full-Text